Review: obliterative bronchiolitis in CTDs is rare, underdiagnosed and lacks standardised therapies
A review shared by ERS publications says evidence on obliterative bronchiolitis in CTDs is limited and highlights the need for multicentre studies.
“No standardised therapies exist and evidence is limited.”— ERS publications
A review describes obliterative bronchiolitis as a rare and underdiagnosed pulmonary manifestation of CTDs, according to a post on X from ERS publications.
The post states that no standardised therapies exist for the condition and that the evidence base is limited.
According to the post, the review summarises current knowledge on the topic. It also highlights the need for multicentre studies.
The post did not give details of the review's methods, authors or specific findings, and it did not name the journal in which the review appears. The ERS publications account lists the European Respiratory Journal, European Respiratory Review, ERJ Open Research, Breathe, the ERS Monograph and ERS Handbooks, and the European Lung White Book in its profile.
Original source
“No standardised therapies exist and evidence is limited.”
— ERS publications View the post on X
